Abnormal movements in Hong Kong stocks | Shinda Biotech (01801.HK) plunges by over 6%, with multiple large transactions occurring before market opening, involving a total of over 1.2 billion Hong Kong dollars.

According to the Wise Finance APP, Sino Biopharmaceutical (01801.HK) plummeted by over 6%, as of the time of publication, dropping 5.43% to 87 Hong Kong dollars, with a transaction volume of 1.86 billion Hong Kong dollars.